Translational Research Cancer Centers Consortium
Translational Research Cancer Centers Consortium
Expediting Progress in Cancer Immunotherapy
__________________________________________________________________________________
TRCCC was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. The organization has successfully brought together leaders in this field to advance science, collaboration and clinical trials to help individuals diagnosed with cancer.
23rd TRCCC Annual Meeting
Seven Springs Mountain Resort
Seven Spring, Pennsylvania
March 4-6, 2020
Organizing Center:
Meeting Co-Chairs:
Copyright Translational Research Cancer Centers Consortium
The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.